Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Banyu presents preclinical pharmacokinetic, metabolic data for J-107088 at recent scientific meeting

Nov. 9, 1999

Novel class of bifunctional anticancer agents discovered at University of Kansas

Nov. 8, 1999

Pharmacia & Upjohn describes anthracycline glycosides and their antitumor activity

Nov. 8, 1999

Interim data fom phase II IntraDose trial in liver cancer indicate positive response

Nov. 8, 1999

Merck dedicates significant resources to development of nonpeptide GnRH antagonists

Nov. 5, 1999

Magainin to begin additional clinical trials of squalamine

Nov. 5, 1999

Lilly discloses methods of inhibiting multidrug resistance

Nov. 4, 1999

Results from lead-in phase of Xcytrin trial support continued patient enrollment

Nov. 4, 1999

NewBiotics enters agreement with Ilex for colon cancer therapy

Nov. 3, 1999

New cyclin-dependent kinase inhibitors in the Boehringer Ingelheim pipeline

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...